We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Eugenio Cingolani MD

Eugenio Cingolani MD

Assistant Professor of Medicine, Director, Cardiogenetics-Familial Arrhythmia Program, Division of Cardiology, Electrophysiology Section, Cedars Sinai Heart Institute, Los Angeles, California

Recent Contributions to PracticeUpdate:

  1. MY APPROACH to Stem Cell Therapy for Heart Failure Patients: Not All Cells Are Created Equally
  2. Allogeneic vs Autologous Mesenchymal Stem Cells for Non-lschemic Dilated Cardiomyopathy
  3. Combination Cytokine and Marrow Progenitor in Cardiomyopathy
  4. Bone Marrow–Derived Mesenchymal Stromal Cell Treatment in Ischemic Heart Failure
  5. Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy

Most Read This Week

Recently Updated